Lupitidin

Lupitidin
(IUPAC) ime
	2-({2-[({5-[(dimetilamino)metil]furan-2-il}metil)sulfanil]etil}amino)-5-[(6-metilpiridin-3-il)metil]pirimidin-4(3H)-on
Klinički podaci
Identifikatori
CAS broj	83903-06-4
ATC kod	nije dodeljen
PubChem	51670
ChemSpider	3577726
UNII	WF028DWK9N
KEGG	D04794
Hemijski podaci
Formula	C21H27N5O2S
Mol. masa	413,54 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C21H27N5O2S.3ClH/c1-14-4-5-15(11-24-14)10-16-12-25-20(26-19(16)27)23-8-9-29-13-17-6-7-18(28-17)21(2,3)22;;;/h4-7,11-12H,8-10,13,22H2,1-3H3,(H2,23,25,26,27);3*1H ; Key: HHRDZACHVMGHOB-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Lupitidin je antagonist H₂ receptora. On deluje kao agens protiv čireva.

Reference[uredi | uredi kod]

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

	Portal Medicina
	Portal Hemija